Back to All Collaborations

WIPO Re:Search

Active Since: 2011

Multi-Company Partnership

Contributing to SDGs…

Accelerating the discovery and development of technologies for neglected tropical diseases, malaria, and tuberculosis by sharing intellectual property with the global health research community, catalyzing and fostering global health collaborations, and contributing to capacity-building in low- and middle-income countries.

WIPO Re:Search Resource Platform

PARTNER ORGANISATIONS

  • Academia or research institute

    Aberystwyth University

    African Institute of Biomedical Science and Technology (AiBST)

    California Institute of Technology

    Council on Health Research for Development

    Drugs for Neglected Diseases initiative (DNDi)

    Emory University

    Indian Council of Medical Research

    Infectious Disease Research Institute (IDRI)

    International Vaccine Institute

    Kenya Medical Research Institute

    Kumasi Centre for Collaborative Research in Tropical Medicine

    Liverpool School of Tropical Medicine

    Mahidol University

    Massachusetts Institute of Technology

    McGill University

    Murdoch Childrens Research Institute

    National University of Singapore

    Nigerian Institute of Medical Research

    Sabin Vaccine Institute

    South African Medical Research Council

    Stanford University

    Tulane University

    University of Bamako

    University of British Columbia

    University of Buea

    University of Calgary

    University of Dundee

    University of Edinburgh

    University of Florida

    University of Ibadan

    University of Kansas

    University of Lagos

    University of Mauritius

    University of New South Wales

    University of South Florida

    University of Vermont

    University of Washington

    University of Yaound

    Walter and Eliza Hall Institute of Medical Research

    Walter Reed Army Institute of Research

    Addis Ababa University

    Ahmadu Bello University

    Armauer Hansen Research Institute

    Bandung Institute of Technology

    Biomedical Center of the Central University of Ecuador

    Case Western Reserve University

    Center for Molecular Dynamics Nepal

    Center for World Health Medicine

    Centre for Plant Medicine Research

    Congolese Foundation for Medical Research

    Griffith Institute for Drug Discovery

    Health Sciences Research Institute

    Icahn School of Medicine at Mount Sinai

    Institute of Molecular and Cellular Biology of Rosario

    International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)

    James Cook University

    LifeArc

    Makerere University

    McMaster University

    Medical Research Institute - Alexandria University

    Monash University

    Northeastern University

    Public Health Research Institute

    Seattle Children's Research Institute

    Social Medicine Institute - Rio de Janeiro State University

    Texas Children’s Hospital Center for Vaccine Development

    George Washington University

    Umaru Musa Yar’adua University

    Université Paris-Sud

    University Cheikh Anta Diop of Dakar

    University of Bamenda

    University of California, Berkeley

    University of California, San Diego (UCSD)

    University of California, San Francisco

    University of Campinas

    University of Dschang

    University of Georgia

    University of Ghana

    University of Melbourne

    University of Papua New Guinea - School of Medicine and Health Sciences

    University of São Paulo

    University of South Carolina

    University of Texas - Southwestern Medical Center

    University of Toronto

    University of Zambia

    Usmanu Danfodiyo University, Sokoto

    Washington University in St. Louis

    National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand

    National Institute for Medical Research (NIMR)

    National Institute of Immunology, India

    Research Institute for Tropical Medicine

    Theodor Bilharz Research Institute

    Institut Pasteur Korea

    Noguchi Memorial Institute for Medical Research

  • Global NGOs

    Africa Fighting Malaria

    Developing World Health

    FIND Diagnostics

    PATH Malaria Vaccine Initiative (MVI)

    Biomedical Research Institute

    Global Alliance for Livestock Veterinary Medicines (GALVmed)

    Institut Pasteur

    Malaria Consortium

    Structural Genomics Consortium

  • Government

    Centre Pasteur du Cameroun

    US National Institutes of Health (NIH)

    US Patent and Trademark Office

    Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences

    Kenya Agricultural & Livestock Research Organisation

    National Institute of Industrial Property

    National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention

    Oswaldo Cruz Foundation

    Eijkman Institute for Molecular Biology

  • Hospitals/Health Facilities

    International Hospital Federation (IHF)

    Massachusetts General Hospital

  • Intergovernmental Organizations and Multilaterals

    European Commission

    International Centre for Genetic Engineering and Biotechnology

  • Local NGOs

    Bibliotheca Alexandrina

    Brazilian Biosciences National Laboratory

    Burnet Institute

    Institut Pasteur de Madagascar

    Institut Pasteur de Tunis

    Operation ASHA

    Puerto Rico Science, Technology & Research Trust

  • Private foundation or development organization

    Swiss Tropical and Public Health Institute (Swiss TPH)

  • Product development partnerships

    Medicines for Malaria Venture (MMV)

  • Professional and trade associations

    Association of University Managers

    International Federation of Intellectual Property Attorneys

    Licensing Executive Society International

    Public Interest Intellectual Property Advisors

    IFPMA

  • Life sciences

    Salvensis

Objectives

  • Accelerating development of new vaccines, diagnostics, and drugs for malaria, tuberculosis (TB) and Neglected Tropical Diseases (NTDs).
  • To create partnerships that connect private industry’s assets and resources with qualified academic and nonprofit researchers with novel product discovery or development ideas.
  • Guiding principles to ensure products are available royalty free in least developed countries.

Partnership activities and how they address needs and challenges

WIPO Re:Search, a global consortium, was founded by the World Intellectual Property Organization (WIPO) in partnership with BIO Ventures for Global Health (BVGH) and several leading pharmaceutical companies in 2011. Consortium partners recognized the need to accelerate the development of new drugs, vaccines, and diagnostics for infectious diseases. Today, WIPO Re:Search continues to advance sharing of intellectual property toward R&D for neglected tropical diseases (NTDs), malaria, and tuberculosis.

As the Partnership Hub administrator of WIPO Re:Search, BIO Ventures for Global Health (BVGH) proactively examines scientists’ current neglected disease research and proposes novel collaboration opportunities with other Members. BVGH also fields requests from researchers, identifies Member organizations able to fulfill these requests, and helps forge mutually beneficial collaborations with clearly-defined roles, responsibilities, and expectations.

The World Intellectual Property Organization (WIPO) manages the WIPO Re:Search Resource Platform, a searchable, public database of available intellectual property assets and resources. WIPO Re:Search provides access to important IP resources to support its member organizations in  research on vaccines, diagnostics, and drugs for NTDs, striving ultimately to improve the lives of those most in need. WIPO Re:Search Members include prestigious academic institutions and some of the world’s leading pharmaceutical companies..

Public-Private Partnership Activities

Eisai Co., Ltd. activities: Through WIPO Re:Search, Eisai has collaborated recently with University of Yaoundé I; Infectious Disease Research Institute; and University of Buea on solutions to neglected infectious diseases including human African trypanosomiasis, leishmaniasis, malaria, onchocerciasis, and tuberculosis.

GSK activities: Through WIPO Re:Search, GSK has collaborated recently with Washington University in St. Louis; University of California, San Francisco; and Fundação Oswaldo Cruz on solutions to neglected infectious diseases including Chagas disease and malaria.

Johnson & Johnson activities: Through WIPO Re:Search, Johnson & Johnson has collaborated recently with the Walter and Eliza Hall Institute of Medical Research; Washington University in St. Louis; National Institutes of Health; and University of Yaoundé I on solutions to neglected infectious diseases including human African trypanosomiasis, leishmaniasis, malaria, and tuberculosis.

Merck KGaA, Darmstadt, Germany activities: Through WIPO Re:Search, Merck KGaA has collaborated recently with University of California, San Diego; University of Yaoundé I; and University of Buea on solutions to neglected infectious diseases including Buruli ulcer, Chagas disease, human African trypanosomiasis, leishmaniasis, and onchocerciasis. Merck KGaA is known as EMD in the US and Canada.

MSD activities: Through WIPO Re:Search, MSD has collaborated recently with Seattle Children’s Research Institute/Seattle Structural Genomics Center for Infectious Disease; The George Washington University; and Walter and Eliza Hall Institute of Medical Research on solutions to neglected infectious diseases including malaria, schistosomiasis, and tuberculosis. MSD is a trademark of Merck & Co., Inc., Kenilworth, NJ, USA.

Novartis Pharma AG activities: Through WIPO Re:Search, Novartis has collaborated recently with Nigerian Institute of Medical Research; Brazilian Biosciences National Laboratory; and Public Health Research Institute on solutions to neglected infectious diseases including Chagas disease and malaria.

Pfizer Inc. activities: Through WIPO Re:Search, Pfizer has collaborated recently with Kenya Medical Research Institute; Washington University in St. Louis/The George Washington University; and Infectious Disease Research Institute on solutions to neglected infectious diseases including malaria and tuberculosis.

Takeda Pharmaceutical Company Limited activities: Through WIPO Re:Search, Takeda has collaborated recently with National Institutes of Health; Infectious Disease Research Institute; and Seattle Children’s Research Institute on solutions to neglected infectious diseases including Chagas disease, leishmaniasis, and malaria.

 

Quote
Elimination and eradication of malaria, tuberculosis, and neglected tropical diseases (NTDs) requires the coordinated efforts of international stakeholders from both the corporate and non-profit sectors. WIPO Re:Search is a unique and effective public-private partnership model for accelerating malaria, tuberculosis, and NTD R&D through the free sharing of IP assets.
Jennifer Dent
President, BIO Ventures for Global Health
One of the very best things that has happened to me and my institute in the recent past is being a member of WIPO Re:Search. WIPO Re:Search connects us with collaborators from developed countries. This is a feat that we have not been able to achieve for decades.
Olaoluwa Pheabian Akinwale
Director of NTD Research, Nigerian Institute of Medical Research

SDGs THE PARTNERSHIP CONTRIBUTES TO

SDG 3: Good Health and Wellbeing

  1. 3.2: Reduce Under-5 Mortality 
  2. 3.3: Communicable Diseases & NTDs

SDG 10: Reduced Inequalities

SDG 17: Partnerships for the Goals 

RESULTS & MILESTONES

Membership has grown to include over 150 organisations representing over 40 countries. Since 2011, 154 research collaborations have been established between Members. 15 of these projects progressed to the next stage of product development. In 2019, there were 54 ongoing collaborations.

Malaria, tuberculosis, Chagas disease, schistosomiasis, and soil-transmitted helminthiases are the top five most common diseases subject to WIPO Re:Search collaborations established to date.

The WIPO Re:Search Fellowship Program is building an international community of researchers to catalyze R&D for neglected diseases. Key impacts include 20 fellowships totaling 100+ months of training and securing grant funding, including over US $750,000 for one fellow.